SWAV Stock Forecast: Riding the Sonic Wave of Innovation in Cardiovascular Treatment
Shockwave Medical is innovating cardiovascular treatment with its Intravascular Lithotripsy technology.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Summary
- Shockwave Medical is innovating cardiovascular treatment with its Intravascular Lithotripsy (IVL) technology, which uses sonic pressure waves for minimally invasive procedures.
- Recent financials showcase robust growth, with a YoY increase of 72% in Q1 2023 revenues and expectations of future growth, making it an appealing target for potential acquisitions.
- Rumors of a takeover from giants like Johnson & Johnson and Medtronic have surfaced, yet irrespective of such speculations, Shockwave’s strong financial performance and differentiated technology make it a compelling investment.
SWAV Stock Forecast: Riding the Sonic Wave of Innovation in Cardiovascular Treatment appeared first on I Know First.
Contact [email protected] for any questions or corrections.






